Nurx—a San Francisco-based telemedicine firm that provides birth-control services—announced Chelsea Clinton will join its board of directors. The startup, launched in 2014, recently raised $36 million in Series B funding in hopes of developing a comprehensive reproductive health platform.
Nurx, currently available in 17 states, allows individuals with a smartphone to consult medical professionals and receive prescriptions for birth control and HIV-prevention medication. Users can also receive referrals for other services.
“With efforts you see around the country to further restrict reproductive health access, we need to set the bar high to connect people with information and birth control access,” Clinton said. “We want to see as much innovation both in for-profit and not-for-profit models for sustained access, and this is a moment where we are more likely to see that in a private company.”
With the recent influx of funding, Nurx executives hope to hire more nurses and further develop its network of medical professionals.